Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Goiter01:27

Goiter

Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Advances in the application of multi-omics in tumor immunotherapy.

Frontiers in genetics·2026
Same author

Building Ligand-Responsive Artificial Signaling Pathways Through Programmable Trans-Acting RNA Circuits in Mammalian Cells.

Angewandte Chemie (International ed. in English)·2025
Same author

Symptom-level interactions between anxiety and internet addiction in Chinese adolescents: a large-scale network and residence difference analysis.

Frontiers in psychiatry·2025
Same author

The effect of bullying victimization on internet addiction: mediated by cyberbullying perpetration and moderated by social support.

BMC public health·2025
Same author

Anti-stigma campaign: the COVID-19 stigma and associated factors among Chinese young students.

Frontiers in public health·2025
Same author

The association between school bullying and internet addiction among adolescents: a moderated mediation model.

Frontiers in public health·2025

Related Experiment Video

Updated: May 17, 2026

Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

Uncommon metastases from differentiated thyroid carcinoma.

Hong-Jun Song1, Yan-Li Xue, Zhong-Ling Qiu

  • 1Department of Nuclear Medicine, Shanghai Sixth People's Hospital, Shanghai Jiao Tong University, 600 Yishan Rd., Shanghai, 200233, China.

Hellenic Journal of Nuclear Medicine
|October 30, 2012
PubMed
Summary

Differentiated thyroid carcinoma (DTC) can spread to unusual sites like the brain or skin, often in advanced cases. Early recognition of these rare metastases is crucial for patient prognosis and treatment planning.

More Related Videos

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma
07:01

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

Published on: April 17, 2013

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
03:55

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Published on: June 9, 2023

Related Experiment Videos

Last Updated: May 17, 2026

Spontaneous Murine Model of Anaplastic Thyroid Cancer
05:39

Spontaneous Murine Model of Anaplastic Thyroid Cancer

Published on: February 3, 2023

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma
07:01

An Orthotopic Mouse Model of Anaplastic Thyroid Carcinoma

Published on: April 17, 2013

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer
03:55

Computer-Aided Three-Dimensional Visualization in the Treatment of Locally Advanced Thyroid Cancer

Published on: June 9, 2023

Area of Science:

  • Oncology
  • Nuclear Medicine
  • Radiology

Background:

  • Differentiated thyroid carcinoma (DTC) typically exhibits indolent behavior and limited metastatic potential.
  • Common sites for DTC metastases include the lungs and bones.
  • Rare metastatic sites, such as the brain, eye, breast, liver, kidney, muscle, and skin, are often overlooked.

Purpose of the Study:

  • To highlight the significance of recognizing rare metastatic presentations of DTC.
  • To emphasize the impact of identifying unusual DTC metastases on clinical decision-making and patient prognosis.
  • To discuss the role of diagnostic imaging in managing DTC with rare metastatic patterns.

Main Methods:

  • Review of clinical cases and literature concerning rare DTC metastases.
  • Analysis of diagnostic utility of Iodine-131 (131I) whole-body scans (WBS).
  • Evaluation of the incremental value of Iodine-131 single-photon emission computed tomography/computed tomography (131I-SPET/CT) in detecting rare metastases.

Main Results:

  • Rare DTC metastases can occur in various unexpected locations, often associated with advanced disease and poorer prognosis.
  • Distinguishing true DTC metastases from false-positive 131I uptake at unusual sites requires careful evaluation.
  • 131I-SPET/CT provides enhanced diagnostic accuracy for identifying these rare metastatic foci.

Conclusions:

  • Differentiated thyroid carcinoma can present with unusual metastatic patterns beyond common sites.
  • Recognition of rare metastases is vital for tailoring individualized treatment strategies.
  • Post-therapy 131I-WBS and 131I-SPET/CT are essential tools in the comprehensive management of DTC patients.